期刊文献+

Cirrhosis and its complications:Evidence based treatment 被引量:18

Cirrhosis and its complications:Evidence based treatment
下载PDF
导出
摘要 Cirrhosis results from progressive fibrosis and is the final outcome of all chronic liver disease. It is among the ten leading causes of death in United States. Cirrhosis can result in portal hypertension and/or hepatic dysfunction. Both of these either alone or in combination can lead to many complications, including ascites, varices, hepatic encephalopathy, hepatocellular carcinoma, hepatopulmonary syndrome, and coagulation disorders. Cirrhosis and its complications not only impair quality of life but also decrease survival. Managing patients with cirrhosis can be a challenge and requires an organized and systematic approach. Increasing physicians’ knowledge about prevention and treatment of these potential complications is important to improve patient outcomes. A literature search of the published data was performed to provide a comprehensive review regarding the management of cirrhosis and its complications. Cirrhosis results from progressive fibrosis and is the final outcome of all chronic liver disease.It is among the ten leading causes of death in United States.Cirrhosis can result in portal hypertension and/or hepatic dysfunction.Both of these either alone or in combination can lead to many complications,including ascites,varices,hepatic encephalopathy,hepatocellular carcinoma,hepatopulmonary syndrome,and coagulation disorders.Cirrhosis and its complications not only impair quality of life but also decrease survival.Managing patients with cirrhosis can be a challenge and requires an organized and systematic approach.Increasing physicians’knowledge about prevention and treatment of these potential complications is important to improve patient outcomes.A literature search of the published data was performed to provide a comprehensive review regarding the management of cirrhosis and its complications.
机构地区 Department of Medicine
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第18期5442-5460,共19页 世界胃肠病学杂志(英文版)
关键词 ASCITES Hepatic encephalopathy Portal hypertension VARICES Portopulmonary hypertension Hepatopulmonary syndrome Ascites Hepatic encephalopathy Portal hypertension
  • 相关文献

参考文献11

  • 1Fernando Bessone.Non-steroidal anti-inflammatory drugs:What is the actual risk of liver damage?[J].World Journal of Gastroenterology,2010,16(45):5651-5661. 被引量:17
  • 2Markus W Nistal,Andrea Pace,Hans Klose,Daniel Benten,Ansgar W Lohse.Hepatopulmonary syndrome caused by sarcoidosis of the liver treated with transjugular intrahepatic portosystemic shunt[J].Thorax.2013(9) 被引量:1
  • 3Hsin‐Ming Wang,Chao‐Hung Hung,Sheng‐Nan Lu,Chien‐Hung Chen,Chuan‐Mo Lee,Tsung‐Hui Hu,Jing‐Houng Wang.Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients[J].Liver Int.2013(5) 被引量:3
  • 4Erica Villa,Calogero Cammà,Marco Marietta,Monica Luongo,Rosina Critelli,Stefano Colopi,Cristina Tata,Ramona Zecchini,Stefano Gitto,Salvatore Petta,Barbara Lei,Veronica Bernabucci,Ranka Vukotic,Nicola De Maria,Filippo Schepis,Aimilia Karampatou,Cristian Caporali,Luisa Simoni,Mariagrazia Del Buono,Beatrice Zambotto,Elena Turola,Giovanni Fornaciari,Susanna Schianchi,Anna Ferrari,Dominique Valla.Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis[J].Gastroenterology.2012(5) 被引量:5
  • 5Maria L. Montes Ramirez,Jose F. Pascual-Pareja,Matilde Sánchez-Conde,Jose I. Bernardino De la Serna,Francisco X. Zamora Vargas,Pilar Miralles,Juan M. Castro,Margarita Ramírez,Isabel Gutierrez,Juan Gonzalez-García,Juan Berenguer,Jose R. Arribas López.Transient elastography to rule out esophageal varices and portal hypertensive gastropathy in HIV-infected individuals with liver cirrhosis[J].AIDS.2012(14) 被引量:1
  • 6María Gabriela Delgado,Susana Seijo,Ismael Yepes,Linette Achécar,Maria Vega Catalina,ángeles García–Criado,Juan G. Abraldes,Joaquín de la Pe?a,Rafael Ba?ares,Agustín Albillos,Jaume Bosch,Juan Carlos García–Pagán.Efficacy and Safety of Anticoagulation on Patients With Cirrhosis and Portal Vein Thrombosis[J].Clinical Gastroenterology and Hepatology.2012(7) 被引量:3
  • 7Huay‐Min WANG,Gin‐Ho LO,Wen‐Chi CHEN,Ping‐I HSU,Hsien‐Chung YU,Chiun‐Ku LIN,Hoi‐Hung CHAN,Wei‐Lun TSAI,Feng‐Woei TSAY,Tsan‐Ping LIU,E‐Ming WANG,Kwok‐Hung LAI.Efficacy of transient elastography in screening for large esophageal varices in patients with suspicious or proven liver cirrhosis[J].Journal of Digestive Diseases.2012(8) 被引量:2
  • 8Javier Fernández,Thierry Gustot.Management of bacterial infections in cirrhosis[J].Journal of Hepatology.2012 被引量:3
  • 9Vandana Khungar,Fred Poordad.Hepatic Encephalopathy[J].Clinics in Liver Disease.2012(2) 被引量:1
  • 10Andrés Cárdenas,Pere Ginès,Paul Marotta,Frank Czerwiec,John Oyuang,Mónica Guevara,Nezam H Afdhal.Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis[J].Journal of Hepatology.2011(3) 被引量:6

二级参考文献97

  • 1Andrade RJ,Lucena MI,Fernández MC,Pelaez G,Pach-koria K,García-Ruiz E,García-Mu?oz B,González-Grande R,Pizarro A,Durán JA,Jiménez M,Rodrigo L,Romero-Gomez M,Navarro JM,Planas R,Costa J,Borras A,Soler A,Salmerón J,Martin-Vivaldi R.Drug-induced liver injury:an analysis of461incidences submitted to the Spanish registry over a10-year period. Gastroenterology . 2005 被引量:1
  • 2Bjornsson E.Review article:drug-induced liver injury in clinical practice. Alimentary Pharmacology and Therapeutics . 2010 被引量:1
  • 3Drug Safety Update Volume2,Issue7,February 2009. . 被引量:1
  • 4Aithal GP,,Day CP.Nonsteroidal anti-inflammatory drug-induced hepatotoxicity. Clinics in Liver Disease . 2007 被引量:1
  • 5Watkins PB,,Seligman PJ,Pears JS,Avigan MI,Senior JR.Us-ing controlled clinical trials to learn more about acute drug-induced liver injury. Hepatology . 2008 被引量:1
  • 6Reuben A,Koch DG,Lee WM.Acute liver failure secondary to drug induced liver injury:causes and consequences(Ab-stract). Hepatology . 2009 被引量:1
  • 7EMEA:European Medicines Agency.European Medicines Agency recommends restricted use of nimesulide-containing medicinal products(on-line). http://www.emea.europa.eu/pdfs/general/direct/pr/43260407en.pdf . 被引量:1
  • 8ANMAT Administración Nacional de Medicamentos Ali-mentos y Tecnología Medica Disposición4087/03(on-line). http://www.anmat.gov.ar . 2009 被引量:1
  • 9Nota informativa de la Agencia Espa?ola del Medicamento sobre Nimesulida. http://www.osanet.euskadi.net/contenidos/informacion/notas_seg_cevime/eu_1676/adjuntos/02-05-06nimesulida.pdf . 2002 被引量:1
  • 10WHO Pharmaceuticals Newsletter2002,No.04. http://apps.who.int/medicinedocs/fr/d/Js4943e/3.1.html . 被引量:1

共引文献30

同被引文献210

引证文献18

二级引证文献155

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部